SPECIES-SPECIFIC DIFFERENCES IN CHAPERONE INTERACTION OF HUMAN AND MOUSE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULES

被引:115
作者
NOSSNER, E
PARHAM, P
机构
[1] STANFORD UNIV,SCH MED,DEPT CELL BIOL,STANFORD,CA 94305
[2] STANFORD UNIV,DEPT MICROBIOL & IMMUNOL,STANFORD,CA 94305
关键词
D O I
10.1084/jem.181.1.327
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previous studies have shown that immature mouse class I molecules transiently associate with a resident endoplasmic reticulum protein of 88 kD that has been proposed to act as a chaperone for class I assembly. Subsequently this protein was demonstrated to be identical to calnexin and to associate with immature forms of the T cell receptor complex, immunoglobulin, and human class I HLA heavy chains. In this paper we define further the interaction of human class I HLA heavy chains with chaperone proteins and find key differencess with the complexes observed in the mouse system. First, calnexin and immunoglobulin binding protein (BiP) both associate with immature HLA class I heavy chains. The two chaperones are not found within the same molecular complex, suggesting that calnexin and BiP do not interact simultaneously with the same HLA class I heavy chain. Second, only free HLA class I heavy chains, and not beta(2)-microglobulin (beta(2)m)-associated heavy chains are found associated with the chaperones. Indeed, addition of free beta(2)m in vitro induces dissociation of chaperone-class I HLA heavy chain complexes. The kinetics for dissociation of the class I HLA heavy chain-chaperone complexes and for formation of the class I HLA heavy chain-beta(2)m complex display a reciprocity that suggests the interactions with chaperone and beta(2)m are mutually exclusive. Mouse class I heavy chains expressed in human cells exhibit the mouse pattern of interaction with human chaperones and human Pam and not the human pattern, showing the difference in behavior is purely a function of the class I heavy chain sequence.
引用
收藏
页码:327 / 337
页数:11
相关论文
共 61 条
  • [1] AHLUWALIA N, 1992, J BIOL CHEM, V267, P10914
  • [2] DIFFERENTIAL TRANSPORT REQUIREMENTS OF HLA AND H-2 CLASS-I GLYCOPROTEINS
    ALEXANDER, J
    PAYNE, JA
    MURRAY, R
    FRELINGER, JA
    CRESSWELL, P
    [J]. IMMUNOGENETICS, 1989, 29 (06) : 380 - 388
  • [3] BETA-2-MICROGLOBULIN IS NOT REQUIRED FOR CELL-SURFACE EXPRESSION OF THE MURINE CLASS-I HISTOCOMPATIBILITY ANTIGEN H-2DB OR OF A TRUNCATED H-2DB
    ALLEN, H
    FRASER, J
    FLYER, D
    CALVIN, S
    FLAVELL, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (19) : 7447 - 7451
  • [4] GENETIC-CONTROL OF HLA-A AND B-ANTIGENS IN SOMATIC-CELL HYBRIDS - REQUIREMENT FOR BETA-2 MICROGLOBULIN
    ARCEGOMEZ, B
    JONES, EA
    BARNSTABLE, CJ
    SOLOMON, E
    BODMER, WF
    [J]. TISSUE ANTIGENS, 1978, 11 (02): : 96 - 112
  • [5] PEPTIDE-INDUCED STABILIZATION AND INTRACELLULAR-LOCALIZATION OF EMPTY HLA CLASS-I COMPLEXES
    BAAS, EJ
    VANSANTEN, HM
    KLEIJMEER, MJ
    GEUZE, HJ
    PETERS, PJ
    PLOEGH, HL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (01) : 147 - 156
  • [6] BETA-2-MICROGLOBULIN FROM SERUM ASSOCIATES WITH MHC CLASS-I ANTIGENS ON THE SURFACE OF CULTURED-CELLS
    BERNABEU, C
    VANDERIJN, M
    LERCH, PG
    TERHORST, CP
    [J]. NATURE, 1984, 308 (5960) : 642 - 645
  • [7] FUNCTIONALLY CONFORMED FREE CLASS-I HEAVY-CHAINS EXIST ON THE SURFACE OF BETA(2) MICROGLOBULIN NEGATIVE CELLS
    BIX, M
    RAULET, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (03) : 829 - 834
  • [8] BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.biochem.59.1.253
  • [9] STRUCTURE OF THE HUMAN CLASS-I HISTOCOMPATIBILITY ANTIGEN, HLA-A2
    BJORKMAN, PJ
    SAPER, MA
    SAMRAOUI, B
    BENNETT, WS
    STROMINGER, JL
    WILEY, DC
    [J]. NATURE, 1987, 329 (6139) : 506 - 512
  • [10] A NEW HLA-LINKED T-CELL MEMBRANE MOLECULE, RELATED TO THE BETA-CHAIN OF THE CLONOTYPIC RECEPTOR, IS ASSOCIATED WITH T3
    BUSHKIN, Y
    POSNETT, DN
    PERNIS, B
    CHANG, YW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (02) : 458 - 473